707 related articles for article (PubMed ID: 26867537)
1. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
2. Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis.
Vasavada BB; Chan CL
Exp Clin Transplant; 2015 Feb; 13(1):46-50. PubMed ID: 25654412
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B- and hepatitis D-virus-related liver transplant: single-center data.
Öcal S; Korkmaz M; Harmancı Ö; Ensaroğlu F; Akdur A; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():133-8. PubMed ID: 25894142
[TBL] [Abstract][Full Text] [Related]
4. Management of recurrent hepatitis C virus after liver transplantation.
Jiménez-Pérez M; González-Grande R; Rando-Muñoz FJ
World J Gastroenterol; 2014 Nov; 20(44):16409-17. PubMed ID: 25469009
[TBL] [Abstract][Full Text] [Related]
5. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
[TBL] [Abstract][Full Text] [Related]
6. Lessons Learned From Review of a Single Center Experience With 500 Consecutive Liver Transplants in a Region With Insufficient Deceased-Donor Support.
Yankol Y; Mecit N; Kanmaz T; Cimsit B; Cakaloglu Y; Acarli K; Kalayoglu M
Exp Clin Transplant; 2016 Apr; 14(2):191-200. PubMed ID: 26030810
[TBL] [Abstract][Full Text] [Related]
7. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
[TBL] [Abstract][Full Text] [Related]
8. A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients.
Chen G; Liu H; Hu ZQ; Bai JH; Liu QY; Zhao YP; Gan XM; Wang F; Wang DD; Ma LJ; Li L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):901-6. PubMed ID: 26011237
[TBL] [Abstract][Full Text] [Related]
9. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
[TBL] [Abstract][Full Text] [Related]
10. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.
Kuzuya T; Katano Y; Kumada T; Toyoda H; Nakano I; Hirooka Y; Itoh A; Ishigami M; Hayashi K; Honda T; Goto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1929-35. PubMed ID: 17914972
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B prophylaxis using lamivudine and individualized low-dose hepatitis B immunoglobulin in living donor liver transplantation.
Jiang L; Yan L; Wen T; Li B; Zhao J; Yang J; Xu M; Wang W
Transplant Proc; 2013; 45(6):2326-30. PubMed ID: 23953544
[TBL] [Abstract][Full Text] [Related]
13. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
14. Management of hepatitis B virus infection after liver transplantation.
Jiménez-Pérez M; González-Grande R; Mostazo Torres J; González Arjona C; Rando-Muñoz FJ
World J Gastroenterol; 2015 Nov; 21(42):12083-90. PubMed ID: 26576093
[TBL] [Abstract][Full Text] [Related]
15. A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.
Lin KH; Chen YL; Lin PY; Hsieh CE; Ko CJ; Lin CC; Ming YZ
Exp Clin Transplant; 2017 Feb; 15(1):65-68. PubMed ID: 28004999
[TBL] [Abstract][Full Text] [Related]
16. Living-donor liver transplant with an interposition graft of the inferior vena cava for hepatocellular carcinoma: beyond the Milan criteria and within the UCSF criteria.
Ahn KS; Kang KJ; Kim HT; Kim YH; Park UJ; Lim TJ; Park TJ; Cho WH
Exp Clin Transplant; 2013 Jun; 11(3):283-6. PubMed ID: 23176663
[TBL] [Abstract][Full Text] [Related]
17. Prognostic evaluation of patients undergoing living-donor liver transplant by APACHE II and MELD scores.
Zhang ZY; Chen R; Zhou ZQ; Peng CH; Zhou GW
Exp Clin Transplant; 2015 Feb; 13(1):41-5. PubMed ID: 24779711
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
19. Outcome of critically-ill children after living-donor liver transplant.
Elgendy H; El Moghazy WM; Nafady-Hego H; Uemoto S
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():100-7. PubMed ID: 25894136
[TBL] [Abstract][Full Text] [Related]
20. Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.
Imai D; Yoshizumi T; Sakata K; Ikegami T; Itoh S; Harada N; Motomura T; Toshima T; Mano Y; Soejima Y; Maehara Y
Transplantation; 2018 Sep; 102(9):e382-e391. PubMed ID: 29912047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]